Page last updated: 2024-12-08

isoarecolone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID146970
CHEMBL ID265553
SCHEMBL ID1538433
MeSH IDM0251449

Synonyms (18)

Synonym
AKOS005444150
1-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)ethanone
STK368575
isoarecolone
CHEMBL265553 ,
1-(1-methyl-3,6-dihydro-2h-pyridin-4-yl)ethanone
ethanone, 1-(1,2,3,6-tetrahydro-1-methyl-4-pyridinyl)-
100752-88-3
1-(1,2,3,6-tetrahydro-1-methyl-4-pyridinyl)ethanone
AB01332064-02
1-(1-methyl-1,2,3,6-tetrahydro-4-pyridinyl)ethanone
SCHEMBL1538433
1-(1,2,3,6-tetrahydro-1-methyl-4pyridinyl)ethanone
YYJCSIKNHFNEQM-UHFFFAOYSA-N
DTXSID70143498
NCGC00340368-01
bdbm50469743
ethanone, 1-(1,2,3,6-tetrahydro-1-methyl-4-pyridinyl)- (9ci)

Research Excerpts

Overview

Isoarecolone is a piperidine derivative with nicotine-like activity. It has a slightly different profile of behavioral actions in rodents.

ExcerptReferenceRelevance
"Isoarecolone is a piperidine derivative with nicotine-like activity, but having a slightly different profile of behavioral actions in rodents."( Isoarecolone-induced enhancement of delayed matching to sample performance in monkeys: role of nicotinic receptors.
Buccafusco, JJ; Gattu, M; Jackson, WJ; Terry, AV, 1995
)
2.46

Actions

ExcerptReferenceRelevance
"Isoarecolone failed to inhibit the binding of the nicotinic ligand [125I]-alpha-bungarotoxin or of the muscarinic ligand [3H]-QNB."( Locomotor activation and dopamine release produced by nicotine and isoarecolone in rats.
Garcha, HS; Stolerman, IP; Whiteaker, P; Wonnacott, S, 1995
)
1.25
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (57.14)18.2507
2000's2 (28.57)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.19

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.19 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.27 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.19)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]